The Reference Group consists of representatives from a range of groups, including consumers, healthcare professionals, pharmaceutical industry and healthcare education providers.
The Reference Group had its inaugural meeting in Canberra on 07 April 2016
The second meeting of the Reference Group was held in Canberra on 12 May 2016
- Reference Group Communique 2 (PDF 24 KB)
- Reference Group Communique 2 (Word 34 KB)
- Presentation 1 – ORC Market Research (PDF 1507 KB)
- Presentation 1 – ORC Market Research (Word 380 KB)
- Presentation 2 – PBS Data Presentation (PDF 357 KB)
- Presentation 2 – PBS Data Presentation (Word 351 KB)
The third meeting of the Reference Group was held in Canberra on 18 August 2016
The fourth meeting of the Reference Group was held in Canberra on 29 November 2016
- Reference Group communique 4 (PDF 94 KB)
- Reference Group communique 4 (Word 26 KB)
- Presentation – TGA Pharmacovigilance (PDF 295 KB)
- Presentation – TGA Pharmacovigilance (Word 402 KB)
A copy of Dr Paul Cornes’s presentation is available upon request by emailing the Quality Use of Medicines Section.
The fifth meeting of the Reference Group was held in Canberra on 11 August 2017
A copy of the TGA Presentation on the evidential basis of marketing approval for biosimilars is available upon request by emailing the Quality Use of Medicines Section.
The sixth meeting of the Reference Group was held in Canberra on 11 May 2018
A copy of Dr Ward's Presentation is available upon request by emailing the Quality Use of Medicines Section.